(Allergan plc)

	AGN latest price $238.5981 (0.1%) ($235.5772 - $239.2931) on Mon. Jun. 6, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.76% (three month average)
RSI	78
Latest Price	$238.5981(0.1%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.9% a day on average for past five trading days.
Weekly Trend	AGN advances 3.7% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(53%)    XLV(51%)    XBI(47%)    ARKG(43%)    IVE(42%)
Factors Impacting AGN price	AGN will decline at least -1.38% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-14%)    IPO(-5%)    SHY(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.38% (StdDev 2.76%)
Hourly BBV	0 ()
Intraday Trend	0.1%

5 Day Moving Average	$235.39(1.36%)
10 Day Moving Average	$229.22(4.09%)
20 Day Moving Average	$222.95(7.02%)
To recent high	-17.3%
To recent low	22.6%
Market Cap	$78.666b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed